Abstract
A 43 year old man with HIV and HCV infection and liver cirrhosis developed fatal lactic acidosis within five days from starting nifedipine for arterial hypertension. Multiple drug interactions, current and accumulated drug toxicities and the reduced liver function, might in combination have led to the acute lactic acidosis.
Keywords: Lactic acidosis, nifedipine, disulfiram, amitriptyline, ritonavir, HIV
Drug Metabolism Letters
Title: Fatal Lactic Acidosis Precipitated by Nifedipine in a Patient Treated with Disulfiram and Antiretrovirals
Volume: 3 Issue: 3
Author(s): Oswald Moling, Giovanni Rimenti, Raffaele Pristera, Claudio Vedovelli, Leonardo Pagani, Greta Spoladore and Peter Mian
Affiliation:
Keywords: Lactic acidosis, nifedipine, disulfiram, amitriptyline, ritonavir, HIV
Abstract: A 43 year old man with HIV and HCV infection and liver cirrhosis developed fatal lactic acidosis within five days from starting nifedipine for arterial hypertension. Multiple drug interactions, current and accumulated drug toxicities and the reduced liver function, might in combination have led to the acute lactic acidosis.
Export Options
About this article
Cite this article as:
Moling Oswald, Rimenti Giovanni, Pristera Raffaele, Vedovelli Claudio, Pagani Leonardo, Spoladore Greta and Mian Peter, Fatal Lactic Acidosis Precipitated by Nifedipine in a Patient Treated with Disulfiram and Antiretrovirals, Drug Metabolism Letters 2009; 3 (3) . https://dx.doi.org/10.2174/187231209789352120
DOI https://dx.doi.org/10.2174/187231209789352120 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing
Current Molecular Medicine Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets Targeting Angiogenesis in Renal Cell Carcinoma
Current Cancer Drug Targets The Renal Epithelial Sodium Channel: Genetic Heterogeneity and Implications for the Treatment of High Blood Pressure
Current Pharmaceutical Design Bioactive Small Molecules: Promising Novel Therapies in Cardiovascular Diseases – PART II
Current Topics in Medicinal Chemistry The Role of Dietary Fats in Hypertension, Obesity and Insulin Resistance: A Comparative Study of Animals and Humans in Fetal and Adult Life
Current Nutrition & Food Science Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
Current Medicinal Chemistry Noradrenaline-mediated Inhibition of Inflammatory Cytokines is Altered in Macrophages from Obese Zucker Rats: Effect of Habitual Exercise
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Role of NPC1L1 in the Regulation of Hepatic Metabolism: Potential Contribution of Ezetimibe in NAFLD/NASH Treatment
Current Vascular Pharmacology SUBJECT INDEX TO VOLUME 4 Current Organic Chemistry
Current Organic Chemistry Roles of miRNA in Cardiovascular Development and Dysfunction
Current Medicinal Chemistry The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Medication Adherence of Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients
Current Rheumatology Reviews Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?
Current Pharmaceutical Design Pharmacogenomics of Essential Hypertension: Are We Going the Right Way?
Cardiovascular & Hematological Agents in Medicinal Chemistry Estrogen Receptor Polymorphisms: Significance to Human Physiology, Disease and Therapy
Recent Patents on DNA & Gene Sequences Infection, its Treatment and the Risk for Stroke
Current Vascular Pharmacology Editorial (Thematic Issue: Sensory Science of Oral Health for Creating New Preventive Medicines)
Current Pharmaceutical Design Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
Current Vascular Pharmacology Vascular Abnormalities in Essential Hypertension
Current Pharmaceutical Design